Authors
Rumi Nishimura, Hiroto Ishiki, Daisuke Takei, Ayumi Okizaki, Naoko Kuzumaki, Masako Yamanaka, Kaori Ichihara, Miwa Aoki, Tatsuya Takagi, Shigeki Yamaguchi, Emi Kubo, Hideaki Hasuo, Hiromichi Matsuoka, Hironori Mawatari, Yoshihisa Matsumoto, Akhila Reddy, Eriko Satomi
Published in
International journal of clinical oncology. Nov 17, 2026. Epub Nov 17, 2026.
Abstract
Several versions of equianalgesic tables using various opioid conversion ratios (CRs) and opioid rotation ratios (ORRs) are utilized globally. The use of several different CRs and ORRs may increase the risk for adverse effects, such as uncontrolled pain and accidental opioid overdose. This study was conducted to clarify the CRs and ORRs in clinical practice in Japan.
A cross-sectional questionnaire survey was conducted from March 7 to 20, 2024, targeting palliative care physicians and pharmacists in the following three professional societies: Japanese Society for Palliative Medicine, Japanese Society for Pharmaceutical Palliative Care and Sciences, and Japanese Association of Supportive Care in Cancer. The primary endpoint was to determine the CRs and ORRs utilized by participants for cancer pain treatment.
A total of 433 valid responses (68.1% physicians and 31.9% pharmacists) were collected. Among the participants, 30.3% had performed more than 30 opioid rotations in the past six months. For most CRs and ORRs obtained from all the participants, values for the median, first quartile, third quartile, and mode were consistent. Among groups categorized by profession and frequency of opioid rotation, no significant differences in median ratios were observed for morphine, hydromorphone and oxycodone. However, significant differences were detected for the ORRs involving intravenous (IV) fentanyl, specifically in the ORRs between IV fentanyl and IV morphine.
High consistency was observed in the CRs and ORRs utilized by physicians and pharmacists in palliative care in Japan.
PMID:
43043585
Bibliographic data and abstract were imported from PubMed on 18 Nov 2026.
Read full publication at:
Please sign in
to see all details.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 9
- Comments 0